Sharekhan

Entero Healthcare Solutions Ltd

Fri 29/08/2025,15:48:20 | NSE : ENTERO

₹ 1182.00-16.20 (-1.35%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 1204.20

Previous Close

₹ 1198.20

Volume

64409

Mkt Cap ( Rs. Cr)

₹5142.75

High

₹ 1204.30

Low

₹ 1179.10

52 Week High

₹ 1584.25

52 Week Low

₹ 1080.00

Book Value Per Share

₹ 386.78

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Entero Healthcare Solutions Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

1182.00

216

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

216

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Entero Healthcare Solutions Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Entero Healthcare So - Copy of Newspaper Publication

    26 Aug 2025, 11:54AM Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication Post dispatch of notice of the 7th Annual General Me
  • Entero Healthcare So - General Updates

    25 Aug 2025, 9:34PM Intimation regarding dispatch of letters to those Shareholders whose email addresses are not registered with Company/RTA/DPs
  • Entero Healthcare So - Updates

    25 Aug 2025, 9:22PM Entero Healthcare Solutions Limited has informed the Exchange regarding dispatch of letters to those Shareholders whose e-mail addresses are not regis
  • Entero Healthcare So - Business Responsibility and Sustainability Reporting (BRSR)

    25 Aug 2025, 9:11PM Submission of Business Responsibility and Sustainability Report for the FY 2024-25
  • Entero Healthcare So - Updates

    25 Aug 2025, 9:07PM Entero Healthcare Solutions Limited has informed the Exchange regarding 'Entero healthcare Solutions Ltd as informed the Exchange regarding 'Submissio
  • Entero Healthcare So - Submission Of Notice Of 7Th Annual General Meeting Scheduled To Be Held On September 18, 2025 At 11:30

    25 Aug 2025, 9:07PM Notice of 7th Annual General Meeting of the Company scheduled to be held on Thursday, September 19, 2025 at 11:30 AM (IST) through VC/ OAVM
  • Entero Healthcare So - Shareholders meeting

    25 Aug 2025, 9:01PM Entero Healthcare Solutions Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 18, 2025.
  • Entero Healthcare So - Reg. 34 (1) Annual Report.

    25 Aug 2025, 8:56PM Submission of Annual Report of the Company for the FY 2024-25.
  • Entero Healthcare So - Copy of Newspaper Publication

    21 Aug 2025, 2:39PM Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication for 7th Annual General Meeting through Video Confer
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    19 Aug 2025, 3:09PM Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- Transcript of Earnings call
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Aug 2025, 3:09PM Entero Healthcare Solutions Limited has informed the Exchange about Transcript
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    11 Aug 2025, 7:05PM Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Recording of Earnings Call/ Conferenc
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Aug 2025, 7:05PM Entero Healthcare Solutions Limited has informed the Exchange about Link of Recording of Earning call on unaudited Financial Results for the quarter e
  • Entero Healthcare So - Copy of Newspaper Publication

    10 Aug 2025, 4:04PM Entero Healthcare Solutions Limited has informed the Exchange about Copy of Newspaper Publication
  • Entero Healthcare So - Investor Presentation

    8 Aug 2025, 10:15PM Entero Healthcare Solutions Limited has informed the Exchange about Investor Presentation
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    8 Aug 2025, 6:23PM Submission of Monitoring Agency report for the quarter ended June 30, 2025
  • Entero Healthcare So - Monitoring Agency Report

    8 Aug 2025, 6:19PM Submission of Monitoring Agency Report issued by ICRA Limited for the quarter ended June 30, 2025.
  • Entero Healthcare So - Unaudited Financial Results For The Quarter Ended June 30, 2025

    8 Aug 2025, 6:11PM Submission of Unaudited Financial Results for the quarter ended June 30, 2025
  • Entero Healthcare So Q1 net profit down 66.67% at Rs 6.96 cr

    8 Aug 2025, 6:10PM The company reported standalone net profit of Rs 6.96 crore for the quarter ended June 30, 2025 as compared to Rs 20.88 crore in the same period last
  • Entero Healthcare So - Outcome of Board Meeting

    8 Aug 2025, 6:05PM Entero Healthcare Solutions Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
  • Entero Healthcare So - Outcome of Board Meeting

    8 Aug 2025, 5:51PM Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on August 08, 2025.
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting

    8 Aug 2025, 5:47PM Outcome of Board Meeting dated August 08, 2025
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    30 Jul 2025, 6:55PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    30 Jul 2025, 6:54PM Intimation of Earnings call on unaudited Financial Results of the Company for the Quarter ended June 30, 2025
  • Entero Healthcare So - Board Meeting Intimation for Approval And Take On Record The Standalone And Consolidated Unaudited Fin

    25 Jul 2025, 9:06PM Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2025 ,inter alia, to c
  • Entero Healthcare So has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:01AM As of June 2025, 52.42% is owned by Promoters and 47.58% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 14.41% and Forei
  • Entero Healthcare So - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    9 Jul 2025, 1:32PM Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2025
  • Entero Healthcare So - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    9 Jul 2025, 1:32PM Certificate under Regulation 74(5) of Securities and Exchange Board of India(Depositories and Participants) Regulations, 2018 for the Quarter ended Ju
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    8 Jul 2025, 1:18PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    8 Jul 2025, 1:17PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on July 15, 2025 at 02:00 PM (IST)
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    26 Jun 2025, 7:50PM Intimation of Schedule of Analyst / Institutional Investor meeting to be held on July 02, 2025 at 03:00 PM (IST)
  • Entero Healthcare So - Analysts/Institutional Investor Meet/Con. Call Updates

    26 Jun 2025, 7:50PM Entero Healthcare Solutions Limited has informed the Exchange about Schedule of meet
  • Entero Healthcare So - Trading Window-XBRL

    25 Jun 2025, 7:23PM Entero Healthcare Solutions Limited has informed the Exchange about Closure of Trading Window
  • Entero Healthcare So - Trading Window

    25 Jun 2025, 7:21PM Entero Healthcare Solutions Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) R
  • Entero Healthcare So - Updates

    18 Jun 2025, 7:53PM Entero Healthcare Solutions Limited has informed the Exchange regarding '' amended Code of Practices and Procedures for Fair Disclosure of UPSI""
  • Entero Healthcare So - ESOP/ESOS/ESPS

    18 Jun 2025, 7:53PM Entero Healthcare Solutions Limited has informed the Exchange regarding Grant of 5900 Options.
  • Entero Healthcare So - Intimation For Grant Of 5,900 Options Pursuant To 'Entero Employee Stock Option Plan 2023' To The Eli

    18 Jun 2025, 7:47PM Intimation for grant of 5900 Options pursuant to \Entero Employees Stock Options Plan 2023\ to the eligible employees of the Company
  • Entero Healthcare So - Board Meeting Outcome for Outcome Of Board Meeting Held On June 18, 2025

    18 Jun 2025, 7:23PM Outcome of Board Meeting held on June 18, 2025
  • Entero Healthcare So - Outcome of Board Meeting

    18 Jun 2025, 7:15PM Entero Healthcare Solutions Limited has informed the Exchange regarding Board meeting held on Jun 18, 2025.
  • Entero Healthcare So - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    4 Jun 2025, 7:20PM Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015- Transcript of Earnings call

Key fundamentals

Evaluate the intrinsic value of Entero Healthcare Solutions Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 1650.38 1626.414 675.232 581.205 486.4381
Liabilities 1650.38 1626.414 675.232 581.205 486.4381
Equity 43.508 43.494 4.112 3.85 0.1002
Gross Profit -30.346 -34.494 -43.916 -53.716 -36.9478
Net Profit 19.181 38.44 -12.455 -40.847 -18.1512
Cash From Operating Activities -109.016 -75.65 -56.909 -44.698 -68.1958
NPM(%) 4.69 12.08 -7 -29.75 -18.17
Revenue 408.67 318.161 177.69 137.286 99.8955
Expenses 439.016 352.655 221.606 191.002 136.8433
ROE(%) 1.13 2.28 -0.74 -2.42 -1.07

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Entero Healthcare Solutions Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 801.40 0.71 72.66 675.39 301.39 0.62
Lotus Eye Hospital and Institute Ltd 116.84 6.98 376.90 2461.03 3.55 0.00
Vaishali Pharma Ltd 12.24 -0.81 408.00 1268.51 3.13 0.00
Astec Lifesciences Ltd 872.70 1.80 0.00 2320.81 -604.77 0.00

Company Info

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Our Company was incorporated as `Entero Healthcare Solutions Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated January 10, 2018, issued by the Registrar of Companies, Central Registration Centre, under the administrative control of the Registrar of Companies, Delhi and Haryana at New Delhi. Subsequently, our Company was converted into a public limited company pursuant to a special resolution passed in the annual general meeting of our Shareholders held on August 7, 2023, and consequently, the name of our Company was changed to `Entero Healthcare Solutions Limited', and a fresh certificate of incorporation dated August 25, 2023, was issued by the RoC.Major events and milestones:2018-Our Company was incorporated in January 2018.2018-Received investment from OrbiMed Asia III Mauritius Limited and IM Investments Trust.-Acquired Novacare Healthcare Solutions Private Limited, which was our first acquisition.2019-Crossed monthly turnover of ? 1000 million.2020-Achieved positive EBITDA in our second year of being operational.-Entered into our first promotion, marketing and distribution partnership with Roche Products (India) Private Limited. 2021 -The Economic Times - Best Healthcare Brands 2021 2022 -Acquired SS Pharma Traders Private Limited, which was our 32nd acquisition. 2024 -The Company informed the Exchange about Acquisition of Peerless Biotech Private Limited and Ujjain Maheshwari Pharma Distributors Private Limited. -The Company BOD Approved Acquisition of Devi Pharma Wellness Private Limited. The Company Acquires 80% paidup equity share capital of Avenir Lifecare Pharma Pvt. Ltd.

Read More

Parent Organisation

Entero Healthcare Solutions Ltd.

Founded

10/01/2018

Managing Director

Mr.Prabhat Agrawal

NSE Symbol

ENTEROEQ

FAQ

The current price of Entero Healthcare Solutions Ltd is ₹ 1182.00.

The 52-week high for Entero Healthcare Solutions Ltd is ₹ 1204.30 and the 52-week low is ₹ 1179.10.

The market capitalization of Entero Healthcare Solutions Ltd is currently ₹ 5142.75. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Entero Healthcare Solutions Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Entero Healthcare Solutions Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Entero Healthcare Solutions Ltd shares.

The CEO of Entero Healthcare Solutions Ltd is Mr.Prabhat Agrawal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT